Skip to main content

Table 1 General characteristics of the study participants

From: FIB-4, APRI, and AST/ALT ratio compared to FibroScan for the assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease in Bandar Abbas, Iran

Variables Values
Age (years) mean ± SD 42.95 ± 10.97
Gender N (%)
 Male 144 (70.2)
 Female 61 (29.8)
AST (U/L) mean ± SD 44.75 ± 22.58
ALT (U/L) mean ± SD 51.57 ± 43.37
Platelet count (/µL) mean ± SD 236,414.63 ± 91,908.84
FibroScan score (kPa) mean ± SD 8.70 ± 5.43
CAP score (dB/m) mean ± SD 307.33 ± 47.62
APRI mean ± SD 0.629 ± 0.661
FIB-4 mean ± SD 1.45 ± 1.27
AST/ALT ratio mean ± SD 0.92 ± 0.25
FibroScan results N (%)
 F1 94 (45.9)
 F2 67 (32.7)
 F3 29 (14.1)
 F4 15 (7.3)
  1. N number, SD standard deviation, AST aspartate aminotransferase, ALT alanine aminotransferase, CAP controlled attenuation parameter, APRI AST to platelet ratio index, FIB-4 fibrosis-4